Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

NCT04774809 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Stopped terminated by sponsor

Conditions

Vitiligo

Interventions

DRUG: Low Dose SHR0302 Ointment BID
DRUG: High Dose SHR0302 Ointment BID
OTHER: Placebo Comparator: Vehicle

Sponsor

Reistone Biopharma Company Limited